Franklin Strategic Series-FRANKLIN BIOTECHNOLOGY DISCOVERY FUND

Compañía	Compartir, %
Contineum Therapeutics, Inc.	2.77
Context Therapeutics Inc.	1.65
Alto Neuroscience, Inc.	1.58
HilleVax, Inc.	1.38
Oruka Therapeutics, Inc.	0.95
Artiva Biotherapeutics, Inc.	0.79
enGene Holdings Inc.	0.7
Merus N.V.	0.66
Satellos Bioscience Inc.	0.63
Kyverna Therapeutics, Inc.	0.57
ABIVAX Société Anonyme	0.29